AMY LECLERE: Open Payments
NPI 1083224844 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 46 payments from 9 companies in 2025. Trend: 2023 $416 · 2024 $795 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $253 |
| Axsome Therapeutics, Inc. | 6 | $123 |
| E.R. Squibb & Sons, L.L.C. | 6 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $107 |
| Vanda Pharmaceuticals Inc. | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 3 | $69 |
| Alkermes, Inc. | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 3 | $53 |
| ABBVIE INC. | 3 | $52 |
Products named: Auvelity, COBENFY, CAPLYTA, FANAPT, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI, UZEDY.
Industry payments across IA — which companies pay providers there.
